Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rhinomed has commercialized multiple Class I nasal medical devices including internal nasal dilators for snoring, sleep and sport (Mute, Turbine) and rhinoswab devices for comfortable, standardized collection of respiratory samples for PCR and rapid antigen testing of viruses such as SARS‑CoV‑2, influenza and RSV, and is developing intranasal drug-delivery applications including INPEAP for mild to moderate sleep apnea, which has completed a pilot Phase 1 trial[2][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhinomed.